4.6 Article

Oligodendrocyte Genes, White Matter Tract Integrity, and Cognition in Schizophrenia

期刊

CEREBRAL CORTEX
卷 23, 期 9, 页码 2044-2057

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/cercor/bhs188

关键词

cognition; DTI; genetics; oligodendrocytes; white matter

资金

  1. Canadian Institutes of Health Research
  2. APA/APIRE Astra-Zeneca Young Minds in Psychiatry Award
  3. NARSAD
  4. National Institutes of Health [K05 MH070047, R01 MH 50740]
  5. Centre for Addiction and Mental Health
  6. CAMH Foundation from the Michael and Sonja Koerner Foundation
  7. Kimel Family
  8. Paul E Garfinkel New Investigator Catalyst Award

向作者/读者索取更多资源

Oligodendrocyte genes and white matter tracts have been implicated in the pathophysiology of schizophrenia and may play an important etiopathogenic role in cognitive dysfunction in schizophrenia. The objective of the present study in 60 chronic schizophrenia patients individually matched to 60 healthy controls was to determine whether 1) white matter tract integrity influences cognitive performance, 2) oligodendrocyte gene variants influence white matter tract integrity and cognitive performance, and 3) effects of oligodendrocyte gene variants on cognitive performance are mediated via white matter tract integrity. We used the partial least-squares multivariate approach to ascertain relationships among oligodendrocyte gene variants, integrity of cortico-cortical and subcortico-cortical white matter tracts, and cognitive performance. Robust relationships among oligodendrocyte gene variants, white matter tract integrity, and cognitive performance were found in both patients and controls. We also showed that effects of gene variants on cognitive performance were mediated by the integrity of white matter tracts. Our results were strengthened by bioinformatic analyses of gene variant function. To our knowledge, this is the first study that has brought together these lines of investigation in the same population and highlights the importance of the oligodendrocyte/white matter pathway in schizophrenia, particularly as it pertains to cognitive function.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Neurosciences

Association of functional connectivity of the executive control network or default mode network with cognitive impairment in older adults with remitted major depressive disorder or mild cognitive impairment

Neda Rashidi-Ranjbar, Tarek K. Rajji, Colin Hawco, Sanjeev Kumar, Nathan Herrmann, Linda Mah, Alastair J. Flint, Corinne E. Fischer, Meryl A. Butters, Bruce G. Pollock, Erin W. Dickie, Christopher R. Bowie, Matan Soffer, Benoit H. Mulsant, Aristotle N. Voineskos

Summary: This study compared resting state functional connectivity in older adults with major depressive disorder (MDD) or mild cognitive impairment (MCI), and found that the alterations in functional connectivity in certain brain networks were associated with an increased risk of cognitive impairment.

NEUROPSYCHOPHARMACOLOGY (2023)

Article Clinical Neurology

Bipolar I and bipolar II subtypes in older age: Results from the Global Aging and Geriatric Experiments in Bipolar Disorder (GAGE-BD) project

Alexandra J. M. Beunders, Federica Klaus, Almar A. L. Kok, Sigfried N. T. M. Schouws, Ralph W. Kupka, Hilary P. Blumberg, Farren Briggs, Lisa T. Eyler, Brent P. Forester, Orestes Forlenza, Ariel Gildengers, Esther Jimenez, Benoit H. Mulsant, Regan E. Patrick, Soham Rej, Martha Sajatovic, Kaylee Sarna, Ashley Sutherland, Joy Yala, Eduard Vieta, Luca M. Villa, Nicole C. M. Korten, Annemieke Dols

Summary: This study compared bipolar I disorder (BD-I) and bipolar II disorder (BD-II) in a large, global sample and found no significant differences between the two in terms of general functioning, cognition, and somatic burden. These findings suggest that the distinction between BD-I and BD-II may not be applicable to geriatric bipolar disorder patients.

BIPOLAR DISORDERS (2023)

Review Pharmacology & Pharmacy

ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 Study

Leen Magarbeh, Claudia Hassel, Maximilian Choi, Farhana Islam, Victoria S. Marshe, Clement C. Zai, Rayyan Zuberi, Roseann S. Gammal, Xiaoyu Men, Maike Scherf-Clavel, Dietmar Enko, Benicio N. Frey, Roumen Milev, Claudio N. Soares, Sagar V. Parikh, Franca Placenza, Stephen C. Strother, Stefanie Hassel, Valerie H. Taylor, Francesco Leri, Pierre Blier, Faranak Farzan, Raymond W. Lam, Gustavo Turecki, Jane A. Foster, Susan Rotzinger, Stefan Kloiber, James L. Kennedy, Sidney H. Kennedy, Chad A. Bousman, Daniel J. Muller

Summary: In this study, the association between six ABCB1 single-nucleotide polymorphisms (SNPs) and antidepressant treatment outcomes was investigated through a systematic review and meta-analysis. No significant association was found between ABCB1 SNPs and antidepressant treatment outcomes in the CAN-BIND-1 sample. However, a significant association between rs1128503 and treatment response was observed in the meta-analysis. These findings provide limited evidence for the implementation of ABCB1 genotyping to inform antidepressant treatment.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

Article Psychiatry

Association analyses of the autosomal genome and mitochondrial DNA with accelerometry-derived sleep parameters in depressed UK biobank subjects

Lindsay M. Melhuish Beaupre, Michael Wainberg, Clement C. Zai, Milos Milic, Daniel Felsky, Gregory Brown, Benjamin Goldstein, Shreejoy J. Tripathy, James L. Kennedy, Vanessa F. Goncalves

Summary: This study conducted genome-wide association studies on UK Biobank participants and found a bidirectional relationship between sleep disturbances and depression, as well as the involvement of mitochondria in sleep biology. The results suggest that common genetic variations and mitochondria may play a role in sleep characteristics among depressed individuals.

JOURNAL OF PSYCHIATRIC RESEARCH (2023)

Article Psychiatry

Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trial

Alastair J. Flint, Kathleen S. Bingham, George S. Alexopoulos, Patricia Marino, Benoit H. Mulsant, Nicholas H. Neufeld, Anthony J. Rothschild, Aristotle N. Voineskos, Ellen M. Whyte, Barnett S. Meyers

Summary: This study aimed to identify a prediction model for the risk of relapse in psychotic depression and examine if predictors moderated the effect of treatment on relapse. The number of depressive episodes, severity of residual depressive symptoms, and psychomotor disturbance predicted the risk of relapse. Multivariable models had an accuracy of 69-70% in predicting relapse. Future research is needed to determine if a combination of clinical and biological variables can improve the accuracy of predicting relapse in psychotic depression.

JOURNAL OF PSYCHIATRIC RESEARCH (2023)

Article Psychiatry

The association of genetic variation in CACNA1C with resting-state functional connectivity in youth bipolar disorder

Xinyue Jiang, Alysha A. Sultan, Mikaela K. Dimick, Clement C. Zai, James L. Kennedy, Bradley J. MacIntosh, Benjamin Goldstein

Summary: This study found that the CACNA1C rs1006737 A allele is associated with resting-state functional connectivity (rsFC) in youth with bipolar disorder (BD) in regions relevant to emotion, executive function, and reward. Future task-based approaches are necessary to further understand the brain connectivity related to CACNA1C in BD.

INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2023)

Review Psychiatry

A systematic review on the effectiveness of dialectical behavior therapy for improving mood symptoms in bipolar disorders

Brett D. M. Jones, Madeha Umer, Mary E. Kittur, Ofer Finkelstein, Siqi Xue, Mikaela K. Dimick, Abigail Ortiz, Benjamin I. Goldstein, Benoit H. Mulsant, Muhammad I. Husain

Summary: This systematic review examined the efficacy of dialectical behavior therapy (DBT) for mood symptoms in patients with bipolar disorder (BD), finding that DBT may be effective in improving core symptoms of BD. However, limited sample sizes, heterogeneity, and high risk of bias in the included trials limit the confidence in this conclusion. Larger, well-designed randomized controlled trials are needed to establish the effectiveness of DBT in BD.

INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2023)

Article Health Care Sciences & Services

Technology-Enabled Collaborative Care for Concurrent Diabetes and Distress Management During the COVID-19 Pandemic: Protocol for a Mixed Methods Feasibility Study

Lenka Vojtila, Diana Sherifali, Rosa Dragonetti, Iqra Ashfaq, Scott Veldhuizen, Farooq Naeem, Sri Mahavir Agarwal, Osnat C. Melamed, Allison Crawford, Philip Gerretsen, Margaret Hahn, Sean Hill, Sean Kidd, Benoit Mulsant, Eva Serhal, Leah Tackaberry-Giddens, Carly Whitmore, Jennifer Marttila, Frank Tang, Seeta Ramdass, Gloria Lourido, Sanjeev Sockalingam, Peter Selby

Summary: This study aims to test the feasibility of a technology-enabled collaborative care (TECC) model for diabetes management and mental health support among adults with T2D. Thirty adults with T2D in Ontario, Canada will participate in an 8-week web-based health coaching program supported by a digital care team. The study results, expected to be available by the end of 2023, will provide valuable insights for supporting individuals with T2D and mental health challenges.

JMIR RESEARCH PROTOCOLS (2023)

Article Clinical Neurology

Neurostructural and neurocognitive correlates of APOE ε4 in youth bipolar disorder

Parnian Puramat, Mikaela K. Dimick, Kody G. Kennedy, Clement C. Zai, James L. Kennedy, Bradley J. MacIntosh, Benjamin Goldstein

Summary: This study found that the APOE epsilon 4 gene is associated with neurostructural differences in individuals with bipolar disorder (BD) and controls, but the regional differences in neurostructures between the two groups were significant. This suggests that APOE epsilon 4 may have important implications for neurodevelopmental processes.

JOURNAL OF PSYCHOPHARMACOLOGY (2023)

Article Psychiatry

Multivariate Associations Among White Matter, Neurocognition, and Social Cognition Across Individuals With Schizophrenia Spectrum Disorders and Healthy Controls

Navona Calarco, Lindsay D. Oliver, Michael Joseph, Colin Hawco, Erin W. Dickie, Pamela DeRosse, James M. Gold, George Foussias, Miklos Argyelan, Anil K. Malhotra, Robert W. Buchanan, Aristotle N. Voineskos, SPINS Grp

Summary: This study found a strong relationship between white matter circuitry and neurocognition and social cognition. The microstructure of the uncinate fasciculus and the rostral body of the corpus callosum played a significant role in this relationship. The participant-wise estimates of white matter microstructure, weighted by cognitive performance, were consistent with the participants' diagnosis and predictive of functional outcomes.

SCHIZOPHRENIA BULLETIN (2023)

Review Psychiatry

Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?

Muhammad Ishrat Husain, Nicole Ledwos, Elise Fellows, Jenna Baer, Joshua D. Rosenblat, Daniel M. Blumberger, Benoit H. Mulsant, David J. Castle

Summary: This article reviews the mechanisms underlying the antidepressant effect of serotonergic psychedelics, including their serotonin 2A agonist effects, impact on brain derived neurotrophic factor and immunomodulatory responses, and disruption of the default mode network. However, further research is needed to validate these mechanisms and determine which theories are supported by robust evidence.

FRONTIERS IN PSYCHIATRY (2023)

Article Medicine, General & Internal

Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant Depression A Randomized Clinical Trial

M. Ishrat Husain, Imran B. Chaudhry, Ameer B. Khoso, Tayyeba Kiran, Nawaz Khan, Farooq Ahmad, John Hodsoll, M. Omair Husain, Haider A. Naqvi, Asad T. Nizami, Nasim Chaudhry, Hazrat A. Khan, Fareed Minhas, Jeffrey H. Meyer, Moin A. Ansari, Benoit H. Mulsant, Nusrat Husain, Allan H. Young

Summary: This study aimed to assess the efficacy and tolerability of adjunctive simvastatin in reducing depressive symptoms in treatment-resistant depression (TRD). The results showed no significant differences between the simvastatin group and the placebo group in primary and secondary outcomes, and there were also no significant differences in adverse effects between the two groups. Therefore, simvastatin did not provide additional therapeutic benefit for depressive symptoms in TRD.

JAMA NETWORK OPEN (2023)

Review Psychiatry

Brain-cognition relationships in late-life depression: a systematic review of structural magnetic resonance imaging studies

Tulip Marawi, Nicholas J. Ainsworth, Peter Zhukovsky, Neda Rashidi-Ranjbar, Tarek K. Rajji, Maria Carmela Tartaglia, Aristotle N. Voineskos, Benoit H. Mulsant

Summary: Most patients with late-life depression (LLD) have cognitive impairment, and at least one-third meet diagnostic criteria for mild cognitive impairment (MCI), a prodrome to Alzheimer's dementia (AD) and other neurodegenerative diseases. However, the mechanisms linking LLD and MCI, and brain alterations underlying impaired cognition in LLD and LLD + MCI remain poorly understood.

TRANSLATIONAL PSYCHIATRY (2023)

Article Psychiatry

Association of polygenic risk for bipolar disorder with grey matter structure and white matter integrity in youth

Xinyue Jiang, Clement C. Zai, Kody G. Kennedy, Yi Zou, Yuliya S. Nikolova, Daniel Felsky, L. Trevor Young, Bradley J. Macintosh, Benjamin I. Goldstein

Summary: This study found a negative association between a polygenic risk score for bipolar disorder (BD-PRS) based on adult genetic data and grey matter structure and white matter integrity in youth. These findings may provide clues for identifying neuroimaging markers of bipolar disorder.

TRANSLATIONAL PSYCHIATRY (2023)

Correction Psychiatry

Culturally adapted psychoeducation for bipolar disorder in a low-resource setting: protocol for a multicentre randomised controlled trial (vol 8, E206, 2022)

M. Ishrat Husain, Madeha Umer, Muqaddas Asif, Ameer B. Khoso, Tayyeba Kiran, Moin Ansari, Huma Aslam, Moti Ram Bhatia, Farasat A. Dogar, M. Omair Husain, Hazrat A. Khan, Ali A. Mufti, Benoit H. Mulsant, Farooq Naeem, Haider A. Naqvi, Claire de Oliveira, M. Sajjad Siddiqui, Asad Tamizuddin, Wei Wang, Juveria Zaheer, Nusrat Husain, Nasim Chaudhry, Imran B. Chaudhry

BJPSYCH OPEN (2023)

暂无数据